Health · Pharma & Biotech · 1 day ago
Brazil suspends Peptistrong supplement and orders all batches recalled
Brazil's health regulator, Anvisa, has ordered all batches of the Peptistrong supplement recalled.
It also suspended the product's production, sale, distribution, advertising and use.
Peptistrong is made by Biostevi Pharma and contains hydrolyzed fava-bean protein.
Anvisa says the ingredient had not undergone the safety assessment required for use in food.
The decision followed evidence that the product was being advertised and sold without that assessment.
This does not by itself show that Peptistrong harms health; the agency reported no associated health damage.
Biostevi Pharma says the measure is preventive and that it will provide technical and documentary explanations to Anvisa.
The suspension remains in place, and all batches are covered by the recall.
Brazil’s health regulator, Anvisa, ordered the recall of all batches of the Peptistrong supplement and suspended its manufacture, sale, distribution, advertising and use.
The order was published in Brazil’s Official Gazette on Friday, October 9, 2026.
Peptistrong is sold as a food supplement and contains hydrolyzed fava bean protein.
Anvisa said the ingredient had not undergone the safety assessment required for use in food, and cited evidence that the product was advertised and sold without that assessment.
The reports said the order did not establish that Peptistrong had caused harm to health.
Biostevi Pharma said the measure was preventive and that there was no record of contamination, quality deviation or a failure in handling.
- Who
- Anvisa and the manufacturer, Biostevi Pharma (Manipulação Stevia Ltda.)
- What
- Anvisa ordered all batches of Peptistrong recalled and suspended the product’s manufacture, sale, distribution, advertising and use.
- When
- Friday, October 9, 2026
- Where
- Brazil
- Why
- Anvisa said the hydrolyzed fava bean protein ingredient had not undergone the required safety assessment for use in food, despite evidence of advertising and sales.
Anvisa
Biostevi Pharma
Reason for the suspension
Anvisa
Anvisa said Peptistrong was advertised and sold without a safety assessment of its hydrolyzed fava bean protein ingredient for use in food.
Biostevi Pharma
Biostevi Pharma said the measure was preventive and said it would provide technical and documentary explanations to Anvisa.
Product safety and compliance
Anvisa
Anvisa said the missing assessment does not by itself prove that the product causes harm to health.
Biostevi Pharma
The company said there was no record of contamination, quality deviation or failure in the handling process, and said it had not violated applicable health regulations or technical standards.
Não houve qualquer descumprimento à legislação sanitária ou às normas técnicas aplicáveis, o que será demonstrado à Anvisa por meio dos esclarecimentos técnicos e documentais cabíveis
This story does not have a timeline yet.
- Product
- Peptistrong
- Ingredient
- Hydrolyzed fava bean protein
- Regulator
- Anvisa, Brazil’s National Health Surveillance Agency
- Manufacturer
- Manipulação Stevia Ltda., known as Biostevi Pharma
- Order date
- October 9, 2026
Sources
Related news
Baby Sleep Gripe Water Recalled After Alcohol Found in Testing
FDA Warns Amazon Over Unapproved Herpes Treatments
Possible Wrong Dose Raises Questions for PDE9 Drug Trials in Heart Failure
Experimental eye drops improve vision in a small study of a rare eye disease
FDA approves atezolizumab with chemotherapy for some stage III colon cancers
Review links drug company gifts to more and less appropriate prescribing
Taboos limit sales of weight-loss drugs in India despite obesity rates
Roche reports year-long results for eye drug Vamikibart
Daily painkiller use can hide the cause of ongoing pain
Swiss oncologist warns US drug pricing pressure could delay cancer therapies
Spain withdraws El Toro supplement after detecting sildenafil
